The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Mi… (NCT04813328) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms
India1,500 participantsStarted 2021-06-01
Plain-language summary
This is a pilot, cross-sectional, sample collection study to characterize the immune response and intestinal microorganisms in people with and without COVID-19 antibodies and helminth infection.
Who can participate
Age range5 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Able to provide informed consent.
Exclusion Criteria:
* Poor venous access precluding venipuncture.
* History of any illness or condition which, in the investigator's judgment, may substantially increase the risk associated with the participant's participation in the protocol, or compromise the scientific objectives.
Participants may be co-enrolled in other studies; however study staff should be notified of co-enrollment.
What they're measuring
1
Number of participants with helminth infections
Timeframe: Day 1
2
Number of participants with SARS-CoV-2 antibodies
Timeframe: Day 1
3
Number of participants with positive malaria test
Timeframe: Day 1
4
Average Differential blood count
Timeframe: Day 1
5
Average Hematocrit levels
Timeframe: Day 1
6
Number of participants with latent tuberculosis infection
Timeframe: Day 1
7
Number of participants with Wuchereria bancrofti infection
Timeframe: Day 1
8
Number of participants with Strongyloides stercoralis infection
Timeframe: Day 1
9
Trial details
NCT IDNCT04813328
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)